AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billion, as Britain's second biggest drugmaker steps up a drive to rebuild its product pipeline via deal-making.
A Chinese firm is close to buying Britain's largest luxury yacht maker by sales, underscoring China's growing appetite for European luxury assets. The Financial Times reports.
Antonio Weiss, Lazard global head of investment banking, discusses the details of the Berkshire-Heinz deal, and weighs in on the emerging trend of foreign capital finding a home in the buyout of U.S. companies.
John Malloy, BlueRun Ventures partners, discusses how the social mapping and navigation app startup has revolutionizes the way people plot their destinations and has generated interest from Google and Facebook.
CNBC's Jon Fortt speaks to Cisco's CEO John Chambers about the company's recent acquisitions, the Sprint-SoftBank deal and challenges in China's market.
China's Shaunghui International announced plans to buy pork producer Smithfield Foods for $4.7 billion. CNBC's Michelle Caruso-Cabrera and Eamon Javers; Peter Navarro, University of California; and Mayor Carter Williams of Smithfield, Virginia discuss.
Anyone who knows anything about business knows that you buy low and sell high. Here's why now just may be that selling-high time.
China is buying America's biggest pork company Smithfield Foods for more than $4.5 billion, with CNBC's Michelle Caruso-Cabrera.
Valeant Pharmaceuticals is acquiring Bausch & Lomb for $8.7 billion, reports CNBC's Seema Mody.
What Yahoo gets out of the Tumblr buy, with CNBC's Jon Fortt; and Alyson Shontell, Business Insider and Larry Fishelson, Dynalink Communications, discuss how the market is reacting to the deal.
David Karp's Tumblr was acquired by Yahoo.com for $1.1 billion, with CNBC's Robert Frank; and CNBC's Julia Boorstin and John Herman, BuzzFeed tech editor, discuss which companies might be next in line.
Yahoo is buying Tumblr for $1.1 billion, and wealthy households in France paid more than 100 percent of their income in taxes in 2012. CNBC's Robert Frank and John Carney discuss.
The tech giant hopes its redesigned look will impress users and investors, reports CNBC's Jon Fortt.
Feike Sijbesma, CEO of DSM, talks about the need for companies to "reinvent" themselves and DSM's acquisition strategy.
Elan stepped up its bid to keep its independence on Monday by agreeing a $1 billion deal to buy 21 percent of the royalties that U.S. company Theravance receives from GlaxoSmithKline.
James Woolery, Cadwalader Wickersham & Taft, discusses the impact of investor activism on public companies.
James Woolery, Cadwalader Wickersham & Taft, provides an insider's look at the some of the biggest mergers and acquisitions on Wall Street.
CNBC's David Faber reports the latest details on Arrowgrass Capital Partners' opposition of FCX's takeover of Plains Exploration.
The Berkshire Hathaway chairman and CEO talks about the Heinz acquisition deal, and gives his views on Fed policies.
After years of on-off talks, Glencore's head Ivan Glasenberg gets to complete the $30 billion acquisition of Xstrata on Thursday, the mining industry's biggest takeover yet.